CN113493388B - Synthesis method of butenafine hydrochloride - Google Patents
Synthesis method of butenafine hydrochloride Download PDFInfo
- Publication number
- CN113493388B CN113493388B CN202010268275.9A CN202010268275A CN113493388B CN 113493388 B CN113493388 B CN 113493388B CN 202010268275 A CN202010268275 A CN 202010268275A CN 113493388 B CN113493388 B CN 113493388B
- Authority
- CN
- China
- Prior art keywords
- butenafine hydrochloride
- reaction
- hcl
- methyl
- naphthylmethylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- SUMAWDZJEIQACJ-UHFFFAOYSA-N 2-methylpyridine-4-carbaldehyde Chemical compound CC1=CC(C=O)=CC=N1 SUMAWDZJEIQACJ-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 229960003273 butenafine hydrochloride Drugs 0.000 title claims abstract description 37
- 238000001308 synthesis method Methods 0.000 title claims description 6
- 238000000034 method Methods 0.000 claims abstract description 35
- MQRIUFVBEVFILS-UHFFFAOYSA-N n-methyl-1-naphthalen-1-ylmethanamine Chemical compound C1=CC=C2C(CNC)=CC=CC2=C1 MQRIUFVBEVFILS-UHFFFAOYSA-N 0.000 claims abstract description 25
- FVEINXLJOJPHLH-UHFFFAOYSA-N p-tert-Butylbenzyl alcohol Chemical compound CC(C)(C)C1=CC=C(CO)C=C1 FVEINXLJOJPHLH-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000003054 catalyst Substances 0.000 claims abstract description 18
- 230000002829 reductive effect Effects 0.000 claims abstract description 16
- 239000012065 filter cake Substances 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 13
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 9
- 239000003960 organic solvent Substances 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims description 42
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 32
- 238000007789 sealing Methods 0.000 claims description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- -1 acONa Chemical compound 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000008367 deionised water Substances 0.000 claims description 11
- 229910021641 deionized water Inorganic materials 0.000 claims description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 5
- 239000007810 chemical reaction solvent Substances 0.000 claims description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 3
- 239000011261 inert gas Substances 0.000 claims description 3
- 239000008096 xylene Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000000047 product Substances 0.000 abstract description 12
- ABJKWBDEJIDSJZ-UHFFFAOYSA-N butenafine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)CC1=CC=C(C(C)(C)C)C=C1 ABJKWBDEJIDSJZ-UHFFFAOYSA-N 0.000 abstract description 9
- 229960002962 butenafine Drugs 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 26
- 239000007788 liquid Substances 0.000 description 17
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 16
- 229910052786 argon Inorganic materials 0.000 description 13
- 239000012295 chemical reaction liquid Substances 0.000 description 11
- 239000012535 impurity Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 238000001816 cooling Methods 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 description 8
- 230000001738 genotoxic effect Effects 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 6
- 238000007126 N-alkylation reaction Methods 0.000 description 5
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 150000001639 boron compounds Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 231100000024 genotoxic Toxicity 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000004002 naphthaldehydes Chemical class 0.000 description 4
- 238000007670 refining Methods 0.000 description 4
- 229910052707 ruthenium Inorganic materials 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 231100000025 genetic toxicology Toxicity 0.000 description 3
- 231100000086 high toxicity Toxicity 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 3
- MPWSRGAWRAYBJK-UHFFFAOYSA-N (4-tert-butylphenyl)methanamine Chemical compound CC(C)(C)C1=CC=C(CN)C=C1 MPWSRGAWRAYBJK-UHFFFAOYSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- WNLMYNASWOULQY-UHFFFAOYSA-N 4-tert-butylbenzoyl chloride Chemical compound CC(C)(C)C1=CC=C(C(Cl)=O)C=C1 WNLMYNASWOULQY-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229940065285 cadmium compound Drugs 0.000 description 2
- 150000001662 cadmium compounds Chemical class 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- AKEYUWUEAXIBTF-UHFFFAOYSA-N n-methylnaphthalen-1-amine Chemical compound C1=CC=C2C(NC)=CC=CC2=C1 AKEYUWUEAXIBTF-UHFFFAOYSA-N 0.000 description 2
- NSNPSJGHTQIXDO-UHFFFAOYSA-N naphthalene-1-carbonyl chloride Chemical compound C1=CC=C2C(C(=O)Cl)=CC=CC2=C1 NSNPSJGHTQIXDO-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012502 risk assessment Methods 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZOICEQJZAWJHSI-UHFFFAOYSA-N (2,3,4,5,6-pentafluorophenyl)boron Chemical compound [B]C1=C(F)C(F)=C(F)C(F)=C1F ZOICEQJZAWJHSI-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- XMWGTKZEDLCVIG-UHFFFAOYSA-N 1-(chloromethyl)naphthalene Chemical compound C1=CC=C2C(CCl)=CC=CC2=C1 XMWGTKZEDLCVIG-UHFFFAOYSA-N 0.000 description 1
- SQAINHDHICKHLX-UHFFFAOYSA-N 1-naphthaldehyde Chemical compound C1=CC=C2C(C=O)=CC=CC2=C1 SQAINHDHICKHLX-UHFFFAOYSA-N 0.000 description 1
- WUPHOULIZUERAE-UHFFFAOYSA-N 3-(oxolan-2-yl)propanoic acid Chemical compound OC(=O)CCC1CCCO1 WUPHOULIZUERAE-UHFFFAOYSA-N 0.000 description 1
- OKIHXNKYYGUVTE-UHFFFAOYSA-N 4-Fluorothiophenol Chemical compound FC1=CC=C(S)C=C1 OKIHXNKYYGUVTE-UHFFFAOYSA-N 0.000 description 1
- KDVYCTOWXSLNNI-UHFFFAOYSA-N 4-t-Butylbenzoic acid Chemical compound CC(C)(C)C1=CC=C(C(O)=O)C=C1 KDVYCTOWXSLNNI-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 229910021640 Iridium dichloride Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004176 ammonification Methods 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229910052980 cadmium sulfide Inorganic materials 0.000 description 1
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- UCXUKTLCVSGCNR-UHFFFAOYSA-N diethylsilane Chemical compound CC[SiH2]CC UCXUKTLCVSGCNR-UHFFFAOYSA-N 0.000 description 1
- VDCSGNNYCFPWFK-UHFFFAOYSA-N diphenylsilane Chemical compound C=1C=CC=CC=1[SiH2]C1=CC=CC=C1 VDCSGNNYCFPWFK-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000005826 halohydrocarbons Chemical class 0.000 description 1
- 231100000171 higher toxicity Toxicity 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940101494 mentax Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- PARWUHTVGZSQPD-UHFFFAOYSA-N phenylsilane Chemical compound [SiH3]C1=CC=CC=C1 PARWUHTVGZSQPD-UHFFFAOYSA-N 0.000 description 1
- 229920001843 polymethylhydrosiloxane Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000005394 sealing glass Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- LALRXNPLTWZJIJ-UHFFFAOYSA-N triethylborane Chemical compound CCB(CC)CC LALRXNPLTWZJIJ-UHFFFAOYSA-N 0.000 description 1
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention belongs to the technical field of medicine synthesis, and particularly relates to a method for synthesizing butenafine hydrochloride; n-methyl-1-naphthylmethylamine and p-tert-butyl benzyl alcohol are used as raw materials to synthesize the butenafine under the action of a catalyst. Salifying by using HCl/organic solvent, filtering, and drying the filter cake under reduced pressure to obtain butenafine hydrochloride; the product obtained by the invention has higher purity and yield.
Description
Technical Field
The invention belongs to the technical field of medicine synthesis, and particularly relates to a method for synthesizing butenafine hydrochloride.
Background
Butenafine hydrochloride (butenafine hydrochloride), chemical name N- (4-tert-butylphenyl) -N-methyl-1-naphthamine hydrochloride, is an allylamine antifungal agent developed by Japanese scientific Co., ltd, and was first marketed in Japan in 1992 under the trade name Mentax. The product can inhibit the activity of fungus squalene cyclooxygenase with high selectivity, and inhibit the biosynthesis of squalene and ergosterol in fungus body, thereby destroying the generation of fungus cell membrane and leading to fungus death. Has the characteristics of broad antibacterial spectrum, high antibacterial activity, low recurrence rate, small side effect and the like, and is widely applied to clinic. The chemical structure is as follows:
The currently reported synthetic processes for butenafine mainly include the following:
The main process is reported in patent EP221781, CN1597660A, CN1727325A, CN101077858A, yakugaku Zasshi,1991,111 (2): 126-137, journal of Chinese medical industry, 1999, (3): 102-103, etc. Naphthalene (or its downstream intermediate) is used as raw material, firstly chloromethylated to synthesize 1-chloromethylnaphthalene, then reacted with methylamine to produce N-methylnaphthalene methylamine, then reacted with p-tert-butyl benzyl halide to produce butenafine hydrochloride by substitution, salification and other reactions. The route is as follows:
The route has the advantages of readily available raw materials, simple operation and the like. However, the reaction is usually carried out in dry DMF with anhydrous sodium carbonate or anhydrous potassium carbonate as acid-binding agent. DMF has a high boiling point and is inconvenient to recycle; the p-tert-butyl bromobenzyl is usually obtained from p-methyl-tert-Ding Benxiu generation, and the preparation method has the advantages of more byproducts, larger pollution and higher cost, and is not suitable for industrial workshop production because of the strict operations such as reduced pressure distillation and the like for refining the p-tert-butyl bromobenzyl. Meanwhile, due to the fact that the side-chain halohydrocarbon is used in the N-alkylation reaction in excess and the reaction temperature is high, disubstituted impurities are easy to generate, quaternary ammonium salt structural intermediates are further generated, quaternary ammonium salt impurities are easy to generate in the synthesis of finished products, the purity of the products is low, and the total yield is low after further refining (related structures of the impurities are shown as follows).
German application chemistry Angew.chem.int.ed.,2014,53 (41), 11010-11014 reports the preparation of the target product under ruthenium catalysis starting from 1-naphthaldehyde and 4-tert-butylbenzylamine with carbon dioxide as carbon source. The route is as follows:
However, the whole process in this method is complicated to operate and is accompanied by the formation of a large amount of inorganic salt by-products. Moreover, the conversion of the end product described above needs to be carried out at very high pressures [ CO 2/H2 (20/60 bar) ] and requires high equipment operating requirements. In addition, the noble metal ruthenium is used for catalysis, so that the ruthenium catalyst is high in price, and the production cost is high.
Org.chem.,2018,83,11886-11895, under the catalysis of cadmium selenide/cadmium sulfide and visible light, reduced with 4-fluorobenzene thiol, followed by diisopropyl azodicarboxylate (DIAD) and triphenylphosphine. Reacting with methyl iodide in the presence of the catalyst to obtain the target product. The route is as follows:
However, the process uses heavy metal cadmium compounds with high toxicity to synthesize key intermediates, and the limit requirement is extremely low; when the target product is prepared, methyl is introduced by taking methyl iodide with higher toxicity and lower boiling point as a carbon source, N-polyalkylated quaternary ammonium salt impurities are also introduced, and in addition, the generated triphenylphosphine oxide after the reaction has lower yield after repeated refining due to poor solubility.
In addition, in recent years, quality control of crude drugs has been increasingly focused on research on genotoxic (or genotoxic) impurities. The genetic material of human body is damaged when the concentration of the genotoxic impurities is very low, so that the genetic mutation is caused and the occurrence of tumors can be promoted. Therefore, the method has important practical significance in strictly controlling the content of related genotoxic impurities in the production process. In the process, the reactant monohalogenated alkane and naphthaldehyde have genotoxicity warning structures, and risk assessment and strict requirements are required for the reactant monohalogenated alkane and naphthaldehyde.
Patent US5021458 uses 1-naphthoic acid as raw material, and uses thionyl chloride to make chlorination to obtain 1-naphthoyl chloride, then uses the 1- (4-tert-butyl benzene) -N-methyl methylamine to make condensation reaction to obtain N- (4-tert-butyl benzyl) -N-methyl-1-naphthoyl amide, and finally uses lithium aluminium hydride to make reduction and salification so as to obtain the invented butenafine hydrochloride. The route is as follows:
In addition, the patent reports a method for preparing butenafine hydrochloride by using p-tert-butylbenzoic acid as a raw material, chloridizing the p-tert-butylbenzoyl chloride by using thionyl chloride, condensing the p-tert-butylbenzoyl chloride with N-methylnaphthylamine to obtain 4-tert-butyl-N-methyl-N- (methylnaphthylamine) benzamide, and reducing the 4-tert-butyl-N-methyl-N- (methylnaphthylamine) benzamide by using lithium aluminum hydride to form salt. The route is as follows:
However, the two methods need to use acyl chloride with high toxicity and irritation, and have high equipment requirements and need to be carried out in a special reaction room; meanwhile, lithium aluminum hydride with high activity is needed for the reduction reaction, so that the operation risk is high, and meanwhile, the production cost is high, so that the method is not suitable for large-scale preparation.
Patent CN105130823B discloses a method for obtaining butenafine by taking 4-tert-butylbenzylamine as raw material, reacting with 1-naphthoyl chloride and formic acid in organic solvent, taking organosilane compound [ diphenylsilane, diethylsilane, poly (methylhydrosiloxane), phenylsilane ] as reducing agent, and taking nonmetallic boron compound [ triethylboron, tris (pentafluorophenylboron) ] as catalyst to perform N-methylation reaction, and reducing amide bond. The route is as follows:
the literature angel.chem.int.ed. 2015,54,9042-9046 uses 1-naphthoic acid as raw material, and uses formic acid as carbon source to prepare butenafine after phenylboronic acid catalysis and reduction by organosilane compound and nonmetallic boron compound. The route is as follows:
however, the method is applied to organosilane compounds and nonmetallic boron compounds with higher price when carrying out reduction reaction, so that the production cost is higher, and meanwhile, the reaction temperature of the latter is higher, the reaction time is longer, and the method is not suitable for industrial production.
In summary, in the technical processes for preparing butenafine that have been reported, there are mainly the following problems:
(1) The haloalkane is used for N-alkylation reaction, N-peralkylation impurities are easy to generate, and further refining is needed;
(2) The reduction and ammonification process needs to use ruthenium with high price as a catalyst, so that the production cost is high;
(3) The N-alkylation reaction material monohalogenated alkane and naphthaldehyde have a genotoxicity warning structure, and risk assessment and strict requirements are required for the N-alkylation reaction material monohalogenated alkane and naphthaldehyde;
(4) The N-alkyl side chain is introduced through amide reduction, but the method needs to be applied to lithium aluminum hydride or an organosilane compound/nonmetal boron compound as a reducing agent, so that the reaction conditions are more severe, and the production cost is higher;
(5) Heavy metal cadmium compounds with high toxicity are required to be applied in the reductive amination process, so that the detection limit of the finished product is extremely low.
In view of the problems of the prior art, the research and search of a preparation method which has the advantages of mild reaction conditions, simple operation process, high product yield, high purity and low production cost and is suitable for industrial production of the butenafine still needs to be solved at present.
Disclosure of Invention
Aiming at the problems of the existing preparation technology of butenafine, the invention provides a synthesis method of butenafine hydrochloride. The method can effectively avoid N-peralkylation impurities and related genotoxicity warning structure impurities, and the prepared target product has higher purity and yield.
The specific technical scheme of the invention is as follows:
The synthesis method of butenafine hydrochloride comprises the steps of reacting N-methyl-1-naphthylamine with p-tert-butyl benzyl alcohol to obtain butenafine hydrochloride, wherein the reaction formula is as follows:
The synthesis method of the butenafine hydrochloride specifically comprises the following steps:
Under the protection of inert gas, adding a catalyst, N-methyl-1-naphthylmethylamine, p-tert-butyl benzyl alcohol and a reaction solvent into a sealing device, sealing and controlling the temperature until the reaction is finished, extracting by an extracting agent, concentrating an extract under reduced pressure, forming hydrochloride by an HCl/organic solvent, filtering, and drying a filter cake under reduced pressure to obtain the butenafine hydrochloride.
The catalyst is as follows: cp Ir complex catalyst and base combination system; wherein Cp Ir complex is preferably one of [ Cp IrI 2]2、[Cp*IrCl2]2; of these, a combination system of [ Cp ] IrCl 2]2 with a base is particularly preferred.
Preferably, the base is one of NaHCO 3,Na2CO3,K2CO3, acONa, TEA or a combination thereof, with NaHCO 3 being particularly preferred. The alkali can be prepared into aqueous solution of alkali or can be directly added into the reaction.
In another preferred embodiment the catalyst is an Rh based complex catalyst; preferably RhCl (one of PPh 3)3,RhH(PPh3)4;
preferably, the feeding mole ratio of the N-methyl-1-naphthylmethylamine to the p-tert-butyl benzyl alcohol is 1:1.0 to 1.1.
Preferably, the molar ratio of the N-methyl-1-naphthylmethylamine, the Cp-Ir complex catalyst and the base is 1:0.5% -5%: 1 to 10 percent. Of these, 1:2%:5%.
Preferably, the feeding mole ratio of the N-methyl-1-naphthylmethylamine to the Rh complex catalyst is 1:0.5% to 5%, of which 1:2%.
Preferably, the reaction solvent is one or a combination of deionized water, benzene, toluene, xylene, 1, 4-dioxane, acetonitrile, and deionized water is particularly preferred.
Preferably, the sealing device is placed in heating equipment with the temperature of 100-150 ℃ in the temperature control reaction. The heating device can be selected from heating equipment such as oil bath heating, electric heating sleeves, steam heating, electric furnaces and the like. The sealing equipment can be sealing glass tubes, stainless steel reaction kettles with good sealing performance, sealing Schlenk devices and the like. The present invention is preferably validated by Schlenk apparatus.
Preferably, the temperature-controlled reaction time is 5 to 10 hours; detection determinations may also be made.
Preferably, the extraction solvent is one or a combination of dichloromethane, chloroform and ethyl acetate.
Preferably, the HCl/organic solvent is one or a combination of HCl/methanol, HCl/ethanol, HCl/isopropanol, HCl/1, 4-dioxane, HCl/ethyl acetate, with HCl/methanol being particularly preferred;
preferably, the concentration of hydrochloric acid in the HCl/organic solvent is 0.5 to 4mol/L, of which 2mol/L is particularly preferred.
In the present invention, the inert gas is usually nitrogen or argon, and among them, argon is particularly preferable.
Compared with the prior art, the invention has the technical effects that:
(1) The catalyst of the invention enables N-alkylation monosubstituted reaction of p-tert-butyl benzyl alcohol and N-methyl-1-naphthylmethylamine to be carried out, effectively avoids N-peralkylation impurities, has small catalyst dosage, greatly reduces production cost, and improves the yield and purity of the obtained product.
(2) The crude product is refined through one-step salification, and meanwhile, the target product is obtained, the reaction steps are few, the post-treatment is simple, and the method is more suitable for industrial production.
Detailed Description
The invention is further illustrated by the following examples, with the understanding that: the examples of the present invention are intended to be illustrative of the invention and not to be limiting of the invention, so that simple modifications to the invention which are based on the method of the invention are within the scope of the invention as claimed.
The materials used in the experiment: the compound N-methyl-1-naphthylmethylamine is commercially available and can also be prepared by reference to the techniques disclosed in the prior art; the compound p-tert-butyl benzyl alcohol is commercially available and can also be prepared by reference to the techniques disclosed in the prior art; the materials used in the other experiments were not of the indicated source and specification, either commercially available analytically pure or chemically pure.
The invention adopts HPLC to measure the purity of the butenafine, and the chromatographic conditions are as follows:
Chromatographic column: welch Ultimate XB-C 18 (4.6mm. Times.150mm, 3.0 μm);
mobile phase: acetate buffer (18.0 g of sodium acetate, 9.8mL of glacial acetic acid, diluted to 1000mL with water) -methanol-isopropanol (17:70:13);
column temperature: 30 ℃;
detection wavelength: 282nm;
flow rate: 1.0mL/min;
Sample injection amount: 10 mu L.
In the following examples, various processes and methods, which are not described in detail, are conventional methods well known in the art.
Example 1
Under the protection of argon, adding [ Cp ] IrCl 2]2 (1.59 g, 0.002mol), sodium bicarbonate (0.42 g,0.005 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (16.42 g,0.10 mol) and deionized water (150 mL) into a Schlenk device, sealing and placing into an oil bath with a temperature of 110 ℃ until the reaction is completed for 8 hours, cooling the reaction liquid to room temperature, adding dichloromethane (50 mL multiplied by 3) for extraction, merging the extract liquid and concentrating under reduced pressure until the extract liquid is dry, adding HCl/methanol (150 mL,2 mol/L) for salifying, continuously stirring and crystallizing for 2-3 hours, filtering, decompressing and drying a filter cake to obtain butenafine hydrochloride, wherein the yield is 96.3 percent: 99.89%.
Example 2
Under the protection of nitrogen, adding [ Cp ] IrCl 2]2 (1.59 g, 0.002mol), sodium bicarbonate (0.42 g,0.005 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (18.07 g,0.11 mol) and deionized water (150 mL) into a Schlenk device, sealing and placing the device into an oil bath with the temperature of 110 ℃ for reaction for 8 hours, cooling the reaction liquid to room temperature after the reaction is finished, adding dichloromethane (50 mL multiplied by 3) for extraction, merging the extract liquid, concentrating the extract liquid to dryness under reduced pressure, adding HCl/methanol (300 mL,0.5 mol/L) for salifying, continuously stirring and crystallizing for 2-3 hours, filtering, decompressing and drying a filter cake to obtain the butenafine hydrochloride with the yield of 96.8 percent, and performing HPLC:99.80%.
Example 3
Under the protection of argon, adding [ Cp ] IrCl 2]2 (1.59 g, 0.002mol), sodium bicarbonate (0.42 g,0.005 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (18.89 g,0.115 mol) and deionized water (150 mL) into a Schlenk device, sealing and placing the device into an oil bath with the temperature of 110 ℃ for reaction for 8 hours, cooling the reaction liquid to room temperature after the reaction is finished, adding dichloromethane (50 mL multiplied by 3) for extraction, merging the extract liquid and concentrating the extract liquid to dryness under reduced pressure, adding HCl/1, 4-dioxane (150 mL,2 mol/L) for salifying, continuously stirring and crystallizing for 2-3 hours, filtering, decompressing and drying the filter cake to obtain the butenafine hydrochloride with the yield of 95.8 percent, and carrying out HPLC:99.76%.
Example 4
Under the protection of argon, adding [ Cp ] IrCl 2]2 (0.40 g,0.0005 mol), potassium carbonate (0.69 g,0.005 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (16.42 g,0.10 mol) and toluene (150 mL) into a Schlenk device, sealing and placing into an oil bath with the temperature of 130 ℃ for reaction for 10 hours, cooling the reaction liquid to room temperature after the reaction is finished, adding dichloromethane (50 mL multiplied by 3) for extraction, merging the extract liquid and concentrating to dryness under reduced pressure, adding HCl/methanol (150 mL,2 mol/L) for salifying, continuously stirring and crystallizing for 2-3 hours, filtering, decompressing and drying a filter cake to obtain the butenafine hydrochloride, wherein the yield is 90.9 percent: 99.75%.
Example 5
Under the protection of argon, adding [ Cp ] IrCl 2]2 (3.98 g,0.005 mol), sodium bicarbonate (0.42 g,0.005 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (16.42 g,0.10 mol) and deionized water (150 mL) into a Schlenk device, sealing and placing the device into an oil bath with a temperature of 110 ℃ for reaction for 5 hours, cooling the reaction liquid to room temperature after the reaction is finished, adding dichloromethane (50 mL multiplied by 3) for extraction, merging the extract liquid for decompression concentration to dryness, adding HCl/isopropanol (150 mL,2 mol/L) for salifying, continuously stirring and crystallizing for 2-3 hours, filtering, decompressing and drying a filter cake to obtain butenafine hydrochloride with a yield of 92.6%, and carrying out HPLC:99.73%.
Example 6
Under the protection of argon, adding [ Cp ] IrI 2]2 (2.32 g,0.002 mol), triethylamine (0.51 g,0.005 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (16.42 g,0.10 mol) and deionized water (150 mL) into a Schlenk device, sealing and placing the device into an oil bath with the temperature of 110 ℃ until the reaction is carried out for 7 hours, cooling the reaction liquid to room temperature after the reaction is finished, adding dichloromethane (50 mL multiplied by 3) for extraction, merging the extract liquid, concentrating the extract liquid under reduced pressure until the extract liquid is dried, adding HCl/ethanol (150 mL,2 mol/L) for salifying, continuously stirring and crystallizing for 2-3 hours, filtering, decompressing and drying a filter cake to obtain butenafine hydrochloride, wherein the yield is 95.8 percent: 99.84%.
Example 7
Under the protection of argon, adding [ Cp ] IrCl 2]2 (1.59 g, 0.002mol), sodium bicarbonate (0.084 g,0.001 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (16.42 g,0.10 mol) and deionized water (150 mL) into a Schlenk device, sealing and placing the device into an oil bath with a temperature of 110 ℃ for reaction for 9 hours, cooling the reaction liquid to room temperature after the reaction is finished, adding ethyl acetate (50 mL multiplied by 4) for extraction, merging the extract liquid for decompression concentration to dryness, adding HCl/ethyl acetate (150 mL,2 mol/L) for salifying, continuously stirring and crystallizing for 2-3 hours, filtering, decompressing and drying a filter cake to obtain the butenafine hydrochloride with the yield of 90.1 percent, and performing HPLC:99.75%.
Example 8
Under the protection of argon, adding [ Cp ] IrCl 2]2 (1.59 g, 0.002mol), sodium bicarbonate (0.84 g,0.01 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (16.42 g,0.10 mol) and deionized water (150 mL) into a Schlenk device, sealing and placing the device into an oil bath with a temperature of 110 ℃ for reaction for 6 hours, cooling the reaction liquid to room temperature after the reaction is finished, adding chloroform (50 mL multiplied by 3) for extraction, merging the extract liquid for decompression concentration to dryness, adding HCl/methanol (150 mL,2 mol/L) for salifying, continuously stirring and crystallizing for 2-3 hours, filtering, decompressing and drying a filter cake to obtain butenafine hydrochloride, wherein the yield is 89.2 percent: 99.72%.
Example 9
Under the protection of argon, rhCl (PPh 3)3 (1.85 g,0.002 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (16.42 g,0.10 mol) and 1, 4-dioxane (150 mL) are added into a stainless steel reaction kettle, the mixture is placed in an oil bath with the temperature of 150 ℃ in a sealing way until the reaction is carried out for 5 hours, after the reaction is finished, the reaction liquid is cooled to room temperature, dichloromethane (50 mL multiplied by 3) is added for extraction, the combined extract is decompressed and concentrated to dryness, HCl/methanol (150 mL,2 mol/L) is added for salifying, the mixture is continuously stirred and crystallized for 2 to 3 hours and then filtered, and a filter cake is decompressed and dried to obtain butenafine hydrochloride with the yield of 94.5 percent and the HPLC of 99.85 percent.
Example 10
RhH (PPh 3)4 (2.31 g,0.002 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (16.42 g,0.10 mol) and acetonitrile (150 mL) are added into a Schlenk device under the protection of argon gas, the mixture is placed into an oil bath with the temperature of 120 ℃ for 6 hours in a sealing way, after the reaction is finished, the reaction solution is cooled to room temperature, dichloromethane (50 mL multiplied by 3) is added for extraction, the combined extract is concentrated to dryness under reduced pressure, HCl/methanol (150 mL,2 mol/L) is added for salifying, the mixture is filtered after continuous stirring crystallization for 2-3 hours, and a filter cake is dried under reduced pressure, thus obtaining butenafine hydrochloride with the yield of 96.1% and the HPLC of 99.81%.
Example 11
Under the protection of argon, adding [ Cp ] IrCl 2]2 (1.59 g, 0.002mol), sodium bicarbonate (0.42 g,0.005 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (16.42 g,0.10 mol) and benzene (150 mL) into a Schlenk device, sealing and placing the device into an oil bath with the temperature of 110 ℃ for reaction for 8 hours, cooling the reaction liquid to room temperature after the reaction is finished, adding dichloromethane (50 mL multiplied by 3) for extraction, merging the extract liquid and concentrating the extract liquid to dryness under reduced pressure, adding HCl/methanol (150 mL,2 mol/L) for salifying, continuously stirring and crystallizing for 2-3 hours, filtering, decompressing and drying a filter cake to obtain butenafine hydrochloride with the yield of 94.2 percent, and carrying out HPLC:99.87%.
Example 12
Under the protection of argon, adding [ Cp ] IrCl 2]2 (1.59 g, 0.002mol), sodium bicarbonate (0.42 g,0.005 mol), N-methyl-1-naphthylmethylamine (17.12 g,0.10 mol), p-tert-butyl benzyl alcohol (16.42 g,0.10 mol) and xylene (150 mL) into a glass tube, sealing the tube, placing into an electric furnace with a temperature of 140 ℃ for reaction for 5 hours, cooling the reaction liquid to room temperature after the reaction is finished, adding dichloromethane (50 mL multiplied by 3) for extraction, merging the extract liquid and concentrating the extract liquid to dryness under reduced pressure, adding HCl/methanol (150 mL,2 mol/L) for salifying, continuously stirring and crystallizing for 2-3 hours, filtering, decompressing and drying a filter cake to obtain butenafine hydrochloride with a yield of 95.4 percent, and carrying out HPLC:99.85%.
Claims (8)
1. The synthesis method of butenafine hydrochloride is characterized in that N-methyl-1-naphthylmethylamine and p-tert-butyl benzyl alcohol react to obtain butenafine hydrochloride, and the reaction formula is as follows:
;
The method specifically comprises the following steps: under the protection of inert gas, adding a catalyst, N-methyl-1-naphthylmethylamine, p-tert-butyl benzyl alcohol and a reaction solvent into a sealing device, placing the sealing device into heating equipment with the temperature of 100-150 ℃ for sealing and controlling the temperature until the reaction is finished, extracting by an extracting agent, concentrating an extracting solution under reduced pressure, forming hydrochloride by an HCl/organic solvent, filtering, and drying a filter cake under reduced pressure to obtain butenafine hydrochloride;
The catalyst is as follows: a combination of one of [ Cp IrI 2]2 or [ Cp IrCl 2]2 with one or a combination of a base of NaHCO 3、Na2CO3、K2CO3, acONa, TEA, or RhCl (one of PPh 3)3,RhH(PPh3)4).
2. The method for synthesizing butenafine hydrochloride according to claim 1, wherein the base is NaHCO 3.
3. The method for synthesizing butenafine hydrochloride according to claim 1, wherein the molar ratio of N-methyl-1-naphthylmethylamine to p-tert-butyl benzyl alcohol is 1:1.0 to 1.1.
4. The method for synthesizing butenafine hydrochloride according to claim 1, wherein the molar ratio of the N-methyl-1-naphthylmethylamine, cp-Ir complex catalyst, and base is 1:0.5% -5%: 1 to 10 percent.
5. The method for synthesizing butenafine hydrochloride according to claim 1, wherein the molar ratio of the N-methyl-1-naphthylmethylamine to the Rh complex catalyst is 1:0.5 to 5 percent.
6. The method for synthesizing butenafine hydrochloride according to claim 1, wherein the reaction solvent is one or a combination of deionized water, benzene, toluene, xylene, 1, 4-dioxane, acetonitrile.
7. The method for synthesizing butenafine hydrochloride according to claim 1, wherein the reaction solvent is deionized water.
8. The method for synthesizing butenafine hydrochloride according to claim 1, wherein the extraction solvent is one or a combination of dichloromethane, chloroform and ethyl acetate; the HCl/organic solvent is one or a combination of HCl/methanol, HCl/ethanol, HCl/isopropanol, HCl/1, 4-dioxane and HCl/ethyl acetate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010268275.9A CN113493388B (en) | 2020-04-08 | 2020-04-08 | Synthesis method of butenafine hydrochloride |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010268275.9A CN113493388B (en) | 2020-04-08 | 2020-04-08 | Synthesis method of butenafine hydrochloride |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113493388A CN113493388A (en) | 2021-10-12 |
CN113493388B true CN113493388B (en) | 2024-05-10 |
Family
ID=77994773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010268275.9A Active CN113493388B (en) | 2020-04-08 | 2020-04-08 | Synthesis method of butenafine hydrochloride |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113493388B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1727325A (en) * | 2005-06-24 | 2006-02-01 | 焦家良 | Compound of butenafine hydrochloride, preparation method, and application as medication for restraining and killing fungus |
CN101077858A (en) * | 2006-05-24 | 2007-11-28 | 凌沛学 | Method for preparing butenafine hydrochloride |
-
2020
- 2020-04-08 CN CN202010268275.9A patent/CN113493388B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1727325A (en) * | 2005-06-24 | 2006-02-01 | 焦家良 | Compound of butenafine hydrochloride, preparation method, and application as medication for restraining and killing fungus |
CN101077858A (en) * | 2006-05-24 | 2007-11-28 | 凌沛学 | Method for preparing butenafine hydrochloride |
Non-Patent Citations (1)
Title |
---|
Photocatalytic N‑Methylation of Amines over Pd/TiO2 for the Functionalization of Heterocycles and Pharmaceutical Intermediates;Lyu-Ming Wang等;ACS Sustainable Chem. Eng.;第6卷;SI中S4页3.底物合成 * |
Also Published As
Publication number | Publication date |
---|---|
CN113493388A (en) | 2021-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020147861A1 (en) | Electrochemical preparation method for β-trifluoromethylamide compound | |
EP3828170A1 (en) | Method for safely preparing pimavanserin and tartrate salt thereof using triphosgene | |
CN110903248B (en) | Synthesis method of 5-chloro-4-aminopyridazine | |
US20200190056A1 (en) | Processes for the preparation of niraparib and intermediates thereof | |
CN107118215B (en) | A kind of preparation method for treating breast cancer medicines Rui Boxini intermediate | |
CN106432055A (en) | Preparation method of niraparib intermediate 4-(piperidyl-3-yl)aniline | |
US11325922B2 (en) | Process for the preparation of Crisaborole in a stable crystal form | |
CN113493388B (en) | Synthesis method of butenafine hydrochloride | |
CN111793016A (en) | Preparation method of larotinib intermediate and intermediate compound | |
CN113493385B (en) | Method for synthesizing butenafine hydrochloride | |
US11639326B2 (en) | Continuous flow synthesis of ibuprofen | |
CN114105872B (en) | Intermediate for preparing procaterol hydrochloride and preparation method thereof | |
CN107011288B (en) | A kind of preparation method of aripiprazole intermediate 1- (2,3- dichlorophenyl) piperazine hydrochloride | |
CN114195712B (en) | Intermediate capable of being used for preparing procaterol hydrochloride and preparation method thereof | |
CN113493384B (en) | Preparation method of butenafine hydrochloride | |
CN112209837B (en) | Synthesis method of bributin hydrochloride | |
CN113402364A (en) | Preparation method of trimethyl phloroglucinol | |
JP4161290B2 (en) | Process for producing pyrimidinyl alcohol derivatives and synthetic intermediates thereof | |
CN112209838B (en) | Preparation method of butenaphthol hydrochloride | |
CA2757056A1 (en) | A process for dimethylation of active methylene groups | |
CN101723879B (en) | Method for synthesizing (R)-3-ethyl piperidine hydrochloride | |
CN104030942B (en) | A kind of preparation method of L-alpha-amido butanamide hydrochloride | |
CN115403485A (en) | Butenafine intermediate compound | |
CN111302930B (en) | Preparation method of p-phenylbutoxy benzoic acid | |
CN116813479A (en) | Preparation method of butenafine hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |